What is the fair value of INMD stock?

Our analysis estimates the fair value range for INMD to be between $15.04 and $15.37. The current price is $15.06.

What is the analyst price target for INMD?

The average Wall Street analyst price target for INMD is $16.17. This implies a potential upside of 7.3% from current levels.

INMD Stock Analysis: Buy, Sell, or Hold?

INMD - InMode Ltd. Ordinary Shares

Electromedical & Electrotherapeutic Apparatus

$15.06

0.14 (0.94%) ▲

5d: -0.59%

30d: -0.2%

90d: +8.89%

HOLD

MODERATE Confidence

Protect Your INMD Gains

Analysis Updated: Aug 21, 2026 12:00 AM ET

Earnings: Aug 05, 2026 0d

Smart Money Accumulation

Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →

Signal fired Aug 20, 2026 at $14.92 · last confirmed Aug 21, 2026

Strength: 6.0/10

Get Alerted When INMD Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.

100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡

Bottom Line:
📊 HOLD: INMD trades at premium valuation expecting 5.5% growth. Hold existing positions but don't chase. Wait for better entry.

See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

Adjust Growth Assumption: 5.9%

0% (Stagnation) 50% (Hyper Growth)

EST. PRICE IN 2031

$16.42

Based on 5.0% avg growth

INTRINSIC VALUE TODAY

$10.19

Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.4x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: INMD is currently trading at $15.06, which is considered slightly low relative to its 30-day fair value range of $15.04 to $15.37. From a valuation perspective, the stock is trading at a premium (Forward PE: 11.0) compared to its historical average (9.4). At these levels, the market is pricing in 5.5% annual earnings growth.

Technical Outlook: Technically, INMD is in a strong uptrend. The price is currently testing key support at $14.85. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: The stock scores a mixed 57/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position SLIGHTLY LOW

Historical Trading Range $15.04 - $15.37

Company Quality Score 53/100 (HOLD)

Volume Confirmation HIGH

Confidence Score 82.3%

Protect Your Profits

Holding INMD? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

BULLISH: Price oversold vs 30-day range
BULLISH: Options cheap (IV 0th percentile)
NEUTRAL: Mixed technical signals (57/100)
BULLISH: High volume confirmation
NEUTRAL: Near Wall St target ($16.17)
BULLISH: Expecting earnings turnaround to 5.5% growth with None% revenue growth
NEUTRAL: Bottoming setup forming (57/100) — watch for confirmation

Trading Range Analysis

30-Day Trading Range $15.04 - $15.37

Current vs Trading Range SLIGHTLY LOW

Expected Move (7 Days) ±$0.39 (2.6%)

Support & Resistance Levels

Support Level $14.85

Resistance Level $15.38

Current Trend Strong Uptrend

Technical data as of Aug 21, 2026

Fundamental Context

Forward P/E (Next Year Est.) 10.98

Wall Street Target $16.17 (+7.3%)

Earnings Growth (YoY) -31.0%

Profit Margin 20.7%

Valuation Premium vs History +5.5% premium

PE vs Historical 11.0 vs 9.4 STRETCHED

Market-Implied Price Targets If current PE multiple persists

Implied Growth (YoY): +5.5% (market-implied from PE analysis)

1-Year Target $15.89 (+6%)

2-Year Target $16.76 (+11%)

3-Year Target $17.68 (+17%)

3-Yr Target (if PE normalizes) (PE: 11→9) PE COMPRESSION $15.14 (+1%)

Earnings growth offset by PE compression

3-Year Scenarios Using analyst projected EPS growth

Bull: (PE: 20.1, Growth: 5.9%) $32.67 (+117%)

Base: (SPY PE: 11.0, Growth: 5.9%) $17.87 (+19%)

Bear: (PE: 9.3, Growth: 5.9%) $15.19 (+1%)

📈 Valuation based on Current Earnings

RECOVERY PLAY: Stock looks expensive now (12x PE), but valuation improves significantly next year (11x PE) as earnings recover.

Trailing PE: 12.43 | Current EPS (TTM): $1.20

Bull Case $18.76 (+25%)

Analyst growth 14.3%, PE expands to 13.7

Base Case $17.06 (+13%)

Market implied 14.3%, PE stable at 12.4

Bear Case $10.15 (-33%)

Severe decline -20.0%, PE contracts to 10.6

These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.

Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit

bloggers & journalists: you are free to use our charts with attribution.

Last updated: August 22, 2026 9:10 PM ET
Data refreshes hourly during market hours. Next update: 10:10 PM

🔥 Top Stocks Breaking Out Now

Ticker	Score	Recommendation	Change %

See Full Scanner Results »

Technical Signals Check

Is INMD showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check

Insider Activity (6 Months)

Buys

Sells

Net

NEUTRAL

View Insider Activity Scanner

Unlock Insider Activity

See real-time buying/selling by company executives for INMD.

Create Free Account

Already have an account? Log In

Top Rated Medical Devices Stocks

Top-rated stocks in Medical Devices by analyst ratings.

Stock	Analyst Consensus	Analyst Target	Tradestie Score
BSX Boston Scientific Corp	STRONG BUY 34 analysts	$63	49 HOLD
SYK Stryker Corporation	BUY 32 analysts	$383	53 HOLD
PODD Insulet Corporation	STRONG BUY 24 analysts	$172	48 HOLD
EW Edwards Lifesciences Corp	HOLD 32 analysts	$101	49 HOLD
MDT Medtronic PLC	BUY 32 analysts	$98	35 SELL

BSX Boston Scientific…

49 HOLD

SYK Stryker Corporati…

53 HOLD

PODD Insulet Corporati…

48 HOLD

EW Edwards Lifescien…

49 HOLD

MDT Medtronic PLC

35 SELL

Advanced INMD Option Strategies

Professional options setups generated by AI based on today's INMD price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for INMD

INMD Technical Chart INMD Price Prediction INMD Earnings Date INMD Investment Advisor INMD Fair Price Analyzer INMD Options Advisor INMD Options Chain INMD Options Analysis INMD Competitors

InMode Ltd. Ordinary Shares

Electromedical & Electrotherapeutic Apparatus

About

InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.

Exchange: XNAS

Market Cap: $965,835,843

Employees: 599

Listed Since: 2019-08-08

Website: Visit

CIK: 0001742692

Compare INMD with Peers

INMD vs PGNY
Which one to buy?

INMD vs DOCS
Which one to buy?

INMD vs APPS
Which one to buy?

INMD vs BILL
Which one to buy?

INMD vs PUBM
Which one to buy?

INMD vs TNDM

INMD vs DOCS

AACBU vs INMD
Winner: INMD

INMD vs BILL
Winner: INMD

Create New Comparison View All Competitors

Tradestie